References
- Attia R. R., Ebeid A. M., Murray P., Fischer J. E. The placenta as a possible source of gut peptide hormones. Surg. Forum 1976; 27: 432
- Besson J., Malassine A., Ferre F. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase. Regul. Pept. 1987; 19: 197
- Bjøro K., Hovig T., Stokke K. T., Stray-Pedersen S. Formation of prostanoids in human umbilical vessels perfused in vitro. Prostaglandins 1986; 31: 683
- Bjøro K., Stokke K. T., Stray-Pedersen S. Altered angiotensin-prostanoid interactions in umbilical arteries in pregnancy-induced hypertension. Scand. J. Clin. Lab. Invest. 1986; 46: 91
- Bjøro K., Stray-Pedersen S. In vitro perfusion studies on human umbilical arteries. II. Effects of prostacyclin and a thromboxane A2 mimetic. Acta Obstet. Gynecol. Scand. 1986; 65: 467
- Bryant M. G., Buchan A. M.J., Gregor M., Ghatei M. A., Polak J. M., Bloom S. R. Development of intestinal regulatory peptides in the human fetus. Gastro-enterology 1982; 83: 47
- Hansen V., Maigaard S., Allen J., Forman A. Effects of vasoactive intestinal polypeptide and substance P on human intramyometrial arteries and stem villous arteries in term pregnancy. Placenta 1988; 9: 501
- Helm G., Ottesen B., Fahrenkrug J., Larsen J.-J., Owman C., Sjöberg N.-O., Stolberg B., Sundler F., Walles B. Vasoactive intestinal polypeptide (VIP) in the human female reproductive tract: Distribution and motor effects. Biol. Reprod. 1981; 25: 227
- Humphrey C., Munro H., Fischer J. E. In vitro synthesis of vasoactive intestinal peptide: discovery of a large precursor molecule. Surg. Forum 1979; 30: 335
- Laemle L. K. Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in the suprachiasmatic nucleus of the perinatal rat. Dev. Brain Res. 1988; 41: 308
- Lucas A., Bloom S. R., Aynsley-Green A. Vasoactive intestinal peptide (VIP) in preterm and term neonates. Acta Pædiatr. Scand. 1982; 71: 71
- Naeye R. L. Functional important disorders of the placenta, umbilical cord, and fetal membranes. Hum. Pathol. 1987; 18: 680
- Ottesen B., Ulrichsen H., Fahrenkrug J., Larsen J.-J., Wagner G., Schierup L., Søndergaard F. Vasoactive intestinal polypeptide and the female genital tract: Relationship to reproductive phase and delivery. Am. J. Obstet. Gynecol. 1982; 143: 414
- Remuzzi G., Marchesi D., Zoja C., Muratore D., Mecca G., Misiani R., Rossi E., Barbato M., Capetta P., Donati M. B., De Gaetano G. Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins 1980; 20: 105
- Said S. I. Vasoactive intestinal peptide. J. Endocrinol. Invest. 1986; 9: 191
- Said S. I., Mutt V. Polypeptide with broad biological activity: Isolation from small intestine. Science 1970; 169: 1217
- Shulkes A., Henderson T., Hardy K. J. Fetal metabolism and placental transfer of vasoactive intestinal peptide in sheep. Biol. Reprod. 1987; 37: 1
- Wei E. P., Kontos H. A., Said S. I. Mechanism of action of vasoactive intestinal polypeptide on cerebral arterioles. Am. J. Physiol. 1980; 239: H765